Chagas disease
Vertical transmission. A description of clinical cases
Abstract
Chagas disease is a disease caused by Trypanosoma cruzi. In 1997 a certification was issued declaring the interruption of the vectorial transmission of T.cruzi in Uruguay. Within this context, non-vectorial transmission mechanisms became more important. Congenital infection is the only transmission mechanism in the country. This risk (4%) results in specific serologic testing for Chagas being mandatory in obstetric follow up visits of the 13 endemic departments of Uruguay and the maternity of the Pereira Rossell Hospital Center in Montevideo (Decree of the Executive Power N° 49085/95). The objective of the study is to describe five clinical cases of children to mothers with positive serology for Chagas, who were seen at Médica Uruguaya from 2011 through 2014. The mothers of all these children live in Montevideo, three of them used to live in endemic departments during their childhood (Rivera, Artigas, Tacuarembó) and the grandmothers on the mother’s side live in the endemic departments. Xenodiagnosis was negative in four children. Infection was confirmed in one four-year old asymptomatic boy who lived in Montevideo through serological testing.
Conclusions: parasitological treatment must be avoided during pregnancy. Diagnosis prior to 9 months of age requires xenodiagnosis (Instituto de Higiene. School of Medicine, University of the Republic), since serological tests may provide biological false-positive test due to placenta transmission of IgG type maternal antibodies. In this small series, infection was confirmed in one of the five cases. Disease controls requires detection during pregnancy and timely referral, as well as follow up of children until they are one year old to discard the disease.
References
(2) Rosa R, Basmadjián Y, González Murguiondo M, González Arias M, Salvatella R. Actualización clínico-epidemiológica y terapéutica de la enfermedad de Chagas en Uruguay. Rev Méd Urug 2001; 17(2):125-32.
(3) Salvatella R, Agrelo R. Enfermedad de Chagas. Informe de situación en Uruguay. Rev Méd Urug 1993; 9(1): 65-6.
(4) Martínez I, Cervantes-Landin A, Espinoza B. Diagnóstico molecular de la enfermedad de Chagas. Gac Méd Méx 2013; 149(3):363-5.
(5) Cucunubá ZM, Valencia Hernández CA, Puerta CJ, Sosa Estani S, Torrico F, Cortés JA, et al. Primer consenso colombiano sobre Chagas congénito y orientación clínica a mujeres en edad fértil con diagnóstico de Chagas. Infectio 2014; 18(2):50-65.
(6) Blasco L, Nuñez V, Cruceyra M, Magdaleno F, García S. Enfermedad de Chagas y embarazo. Rev Chil Obstet Ginecol 2011; 76(3):162-8.
(7) Freilij H, Altcheh J. Congenital Chagas’ disease: diagnostic and clinical aspects. Clin Infect Dis 1995; 21(3):551-5.
(8) Apt BW, Heitmann I, Jercic I, Jofré L, Muñoz P, Noemí I, et al. Guías clínicas de la enfermedad de Chagas 2006: Parte V. Diagnóstico de laboratorio Rev Chil Infectol 2008; 25(5):379-83.
(9) Altcheh J, Biancardi M, Lapeña A, Ballering G, Freilij H. Enfermedad de Chagas congénita: experiencia del Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina. Rev Soc Bras Med Trop 2005; 38(2):41-5.
(10) Berberian G, Rosanova MT, Kaldzielski C, Paulin P, Castro G, Galina L. Compromiso ocular en la enfermedad de Chagas congénita. Arch Argent Pediatr 2013; 111(3):e78-81.
(11) Bern C, Montgomery SP, Herwaldt B, et al. Evaluation and treatment of Chagas disease in the United States. A systematic review. JAMA 2007; 298:2171-81.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.